The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Evolent Health Inc (NYSE: EVH) was $10.58 for the day, up 1.63% from the previous closing price of $10.41. In other words, the price has increased by $1.63 from its previous closing price. On the day, 1.13 million shares were traded. EVH stock price reached its highest trading level at $10.66 during the session, while it also had its lowest trading level at $10.355.
Ratios:
Our analysis of EVH’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.92 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.25. For the most recent quarter (mrq), Quick Ratio is recorded 1.04 and its Current Ratio is at 1.04. In the meantime, Its Debt-to-Equity ratio is 0.79 whereas as Long-Term Debt/Eq ratio is at 0.79.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on January 10, 2025, initiated with a Buy rating and assigned the stock a target price of $15.
On December 03, 2024, BTIG Research reiterated its Buy rating and also upped its target price recommendation from $36 to $29.
Stephens Downgraded its Overweight to Equal-Weight on November 08, 2024, whereas the target price for the stock was revised from $38 to $16.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 22 ’24 when McCarthy Daniel Joseph sold 23,693 shares for $30.89 per share. The transaction valued at 731,790 led to the insider holds 198,809 shares of the business.
McCarthy Daniel Joseph sold 10,469 shares of EVH for $339,008 on Aug 23 ’24. The PRESIDENT now owns 188,340 shares after completing the transaction at $32.38 per share. On Aug 22 ’24, another insider, Weinberg Jonathan, who serves as the General Counsel of the company, sold 42,140 shares for $31.20 each. As a result, the insider received 1,314,706 and left with 167,027 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EVH now has a Market Capitalization of 1216975104 and an Enterprise Value of 1942767488. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.50 while its Price-to-Book (P/B) ratio in mrq is 1.17. Its current Enterprise Value per Revenue stands at 0.788 whereas that against EBITDA is 15.804.
Stock Price History:
The Beta on a monthly basis for EVH is 1.45, which has changed by -0.6503191 over the last 52 weeks, in comparison to a change of 0.21794415 over the same period for the S&P500. Over the past 52 weeks, EVH has reached a high of $35.00, while it has fallen to a 52-week low of $9.74. The 50-Day Moving Average of the stock is -6.91%, while the 200-Day Moving Average is calculated to be -50.63%.
Shares Statistics:
EVH traded an average of 2.80M shares per day over the past three months and 2807770 shares per day over the past ten days. A total of 115.01M shares are outstanding, with a floating share count of 112.78M. Insiders hold about 3.25% of the company’s shares, while institutions hold 110.54% stake in the company. Shares short for EVH as of 1736899200 were 11290469 with a Short Ratio of 4.04, compared to 1734048000 on 9759756. Therefore, it implies a Short% of Shares Outstanding of 11290469 and a Short% of Float of 11.1899994.
